the challenges in identifying causative polymorphisms and the relatively small proportion of heritability accounted for thus far, many may be wondering:
where do we go from here? Several articles in this issue offer inspiration.
In a Review on p149, Kwiatkowski and colleagues discuss the approaches needed for GWA studies in African populations. The staggering genetic diversity in Africa poses statistical challenges, but it will enable great advances in isolating genetic changes that influence common global disorders, as well as devastating diseases in Africa.
A novel approach for identifying disease-associated variants -one that is based on phylogenetic tree analysis -is described in a Research Highlight on p96. This method linked a common polymorphism to Alzheimer's disease onset, suggesting that innovation will foster future success.
However, another Research Highlight (p94) reminds us of the intricacies of complex disease by emphasizing the importance of epigenetics. For example, some susceptibility alleles for type 2 diabetes were found to be imprinted, so distinguishing paternal and maternal alleles might prove to be valuable for tracking down more of the 'missing heritability' . So, what is the value in this enormous effort to identify genetic contributors to complex disease? New molecular insights are highlighted by these articles, but the potential for more tangible benefits exercises the minds of four experts in our Viewpoint on personalized genomic medicine (p161). How health-care systems harness this expanding knowledge will be a future concern for us all. 
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